Noble Vision Medipharma Private Limited
About Noble Vision Medipharma Private Limited
Data last updated:
Noble Vision Medipharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74900GJ2011PTC067319.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Madhu Srivastava and Naveen Kumar Srivastava.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 423 Navdan Appartments Ram Dew Nagar Sattelite Road, Ahmedabad, Gujarat, India – 380015.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Noble Vision Medipharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 423 Navdan Appartments Ram Dew Nagar Sattelite Road, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Noble Vision Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Noble Vision Medipharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Noble Vision Medipharma Private Limited, buy the company report.
Board of directors of Noble Vision Medipharma Private Limited
Noble Vision Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Srivastava | Director | 30 Sep 2011 | 15 Years 0 Months | Current |
| Naveen Kumar Srivastava | Director | 30 Sep 2011 | 15 Years 0 Months | Current |
Auditor
Noble Vision Medipharma Private Limited is audited by G S W & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G S W & CO | FY 2023 | 013920N |
Shareholding
The shareholding of Noble Vision Medipharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Noble Vision Medipharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Noble Vision Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Noble Vision Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Noble Vision Medipharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Noble Vision Medipharma Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Madhu Srivastava was appointed as Director on 30 Sep 2011.
Frequently asked questions
Noble Vision Medipharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 2011 (15+ years old) and is registered under CIN U74900GJ2011PTC067319.
Noble Vision Medipharma has 2 current directors:
- Madhu Srivastava - Director
- Naveen Kumar Srivastava - Director
The latest financial statements of Noble Vision Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Noble Vision Medipharma is U74900GJ2011PTC067319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noble Vision Medipharma was incorporated on 30 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Madhu Srivastava was appointed as Director on 30 Sep 2011. Naveen Kumar Srivastava was appointed as Director on 30 Sep 2011.
The registered office of Noble Vision Medipharma is at B – 423 Navdan Appartments Ram Dew Nagar Sattelite Road, Ahmedabad, Gujarat, India – 380015.
Noble Vision Medipharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Noble Vision Medipharma is compliant as of 13 July 2026. The company is actively filing with the Registrar of Companies.
Noble Vision Medipharma can be reached at its registered office: B – 423 Navdan Appartments Ram Dew Nagar Sattelite Road, Ahmedabad, Gujarat, India – 380015.